Lincoln [LINCOLN] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
Lincoln
NSE
Loading...
Divi's Laboratories
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lincoln wins in 8 metrics, Divi's Laboratories wins in 12 metrics, with 0 ties. Divi's Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lincoln | Divi's Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.69 | 69.41 | Lincoln |
| Price-to-Book Ratio | 1.63 | 10.69 | Lincoln |
| Debt-to-Equity Ratio | 0.00 | 0.03 | Lincoln |
| PEG Ratio | -1.08 | 107.11 | Lincoln |
| EV/EBITDA | 8.73 | 50.48 | Lincoln |
| Profit Margin (TTM) | 13.71% | 23.89% | Divi's Laboratories |
| Operating Margin (TTM) | 13.19% | 25.60% | Divi's Laboratories |
| EBITDA Margin (TTM) | 13.19% | 25.60% | Divi's Laboratories |
| Return on Equity | 12.26% | 14.64% | Divi's Laboratories |
| Return on Assets (TTM) | 10.33% | 12.94% | Divi's Laboratories |
| Free Cash Flow (TTM) | $737.71M | $2.15B | Divi's Laboratories |
| Dividend Yield | 0.31% | 0.91% | Divi's Laboratories |
| 1-Year Return | -17.29% | 32.34% | Divi's Laboratories |
| Price-to-Sales Ratio (TTM) | 1.74 | 16.59 | Lincoln |
| Enterprise Value | $8.99B | $1,547.23B | Divi's Laboratories |
| EV/Revenue Ratio | 1.43 | 16.03 | Lincoln |
| Gross Profit Margin (TTM) | 54.96% | 60.33% | Divi's Laboratories |
| Revenue per Share (TTM) | $315 | $363 | Divi's Laboratories |
| Earnings per Share (Diluted) | $43.08 | $86.88 | Divi's Laboratories |
| Beta (Stock Volatility) | 0.20 | 0.27 | Lincoln |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lincoln vs Divi's Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lincoln | -0.33% | -9.72% | -0.96% | -7.91% | -3.44% | -36.68% |
| Divi's Laboratories | 0.52% | 0.02% | -9.53% | -1.34% | 4.94% | 0.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lincoln | -17.29% | 85.49% | 121.31% | 152.16% | 152.16% | 152.16% |
| Divi's Laboratories | 32.34% | 65.91% | 88.85% | 402.68% | 1,538.26% | 8,472.13% |
Performance & Financial Health Analysis: Lincoln vs Divi's Laboratories
| Metric | LINCOLN | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹10.98B | ₹1.60T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 589,540 | 509,171 |
| 90 Day Avg. Volume | 218,504 | 351,540 |
| Last Close | ₹542.65 | ₹6,132.50 |
| 52 Week Range | ₹499.00 - ₹979.50 | ₹4,615.55 - ₹7,071.50 |
| % from 52W High | -44.60% | -13.28% |
| All-Time High | ₹979.50 (Dec 09, 2024) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -44.60% | -13.28% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.14% |
| Quarterly Earnings Growth | 0.17% | 0.27% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.24% |
| Operating Margin (TTM) | 0.13% | 0.26% |
| Return on Equity (TTM) | 0.12% | 0.15% |
| Debt to Equity (MRQ) | 0.00 | 0.03 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹335.40 | ₹563.87 |
| Cash per Share (MRQ) | ₹97.95 | ₹132.86 |
| Operating Cash Flow (TTM) | ₹967.87M | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹823.46M | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.31% | 0.91% |
| Last 12-Month Dividend | ₹1.80 | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Lincoln vs Divi's Laboratories
| Metric | LINCOLN | DIVISLAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.69 | 69.41 |
| Forward P/E | N/A | 107.11 |
| PEG Ratio | -1.08 | 107.11 |
| Price to Sales (TTM) | 1.74 | 16.59 |
| Price to Book (MRQ) | 1.63 | 10.69 |
| Market Capitalization | ||
| Market Capitalization | ₹10.98B | ₹1.60T |
| Enterprise Value | ₹8.99B | ₹1.55T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.43 | 16.03 |
| Enterprise to EBITDA | 8.73 | 50.48 |
| Risk & Other Metrics | ||
| Beta | 0.20 | 0.27 |
| Book Value per Share (MRQ) | ₹335.40 | ₹563.87 |
Financial Statements Comparison: Lincoln vs Divi's Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LINCOLN | DIVISLAB |
|---|---|---|
| Revenue/Sales | ₹1.68B | ₹24.10B |
| Cost of Goods Sold | ₹801.52M | ₹9.56B |
| Gross Profit | ₹880.31M | ₹14.54B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹234.93M | ₹6.17B |
| EBITDA | ₹198.39M | ₹8.48B |
| Pre-Tax Income | ₹162.47M | ₹7.33B |
| Income Tax | ₹46.72M | ₹1.88B |
| Net Income (Profit) | ₹115.75M | ₹5.45B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LINCOLN | DIVISLAB |
|---|---|---|
| Cash & Equivalents | ₹134.14M | ₹4.15B |
| Total Current Assets | ₹5.00B | ₹100.81B |
| Total Current Liabilities | ₹1.06B | ₹14.52B |
| Long-Term Debt | N/A | ₹20.00M |
| Total Shareholders Equity | ₹6.72B | ₹149.69B |
| Retained Earnings | N/A | ₹134.00B |
| Property, Plant & Equipment | ₹1.82B | ₹3.19B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LINCOLN | DIVISLAB |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LINCOLN | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 589,540 | 509,171 |
| Average Daily Volume (90 Day) | 218,504 | 351,540 |
| Shares Outstanding | 20.03M | 265.47M |
| Float Shares | 8.79M | 120.74M |
| % Held by Insiders | 0.55% | 0.52% |
| % Held by Institutions | 0.01% | 0.29% |
Dividend Analysis & Yield Comparison: Lincoln vs Divi's Laboratories
| Metric | LINCOLN | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | ₹1.80 | ₹60.00 |
| Last 12-Month Dividend Yield | 0.31% | 0.91% |
| 3-Year Avg Annual Dividend | ₹1.60 | ₹50.00 |
| 3-Year Avg Dividend Yield | 0.35% | 0.70% |
| 3-Year Total Dividends | ₹4.80 | ₹150.00 |
| Ex-Dividend Date | Sep 13, 2024 | Jul 25, 2025 |